IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

EMILY YURBERG

Allopathic & Osteopathic Physicians Internal Medicine Infectious Disease

NPI
1689754491
CMS profile
1236682
Location
NEW YORK, NY

General Payments · PY2021–2024

$3,504.38

  • Reported across 114 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,586.86

55 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Infectious Disease NY All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,586.86 55

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Teva Pharmaceuticals USA, Inc. $445.48 14
Neurocrine BioSciences, Inc. $388.67 12
Gilead Sciences, Inc. $236.01 10
Acerta Pharma LLC $224.53 9
EMD Serono, Inc. $192.26 7
ViiV Healthcare Company $57.16 2
E.R. Squibb & Sons, L.L.C. $42.75 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $230.29 5
PY2022 $617.56 18
PY2023 $1,069.67 36
PY2024 $1,586.86 55

Payment records · PY2024 (55)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $27.60 02/15/2024 Food and Beverage Undisputed 01/23/2026 1105544551 CMS
AstraZeneca Pharmaceuticals LP $31.21 03/12/2024 Food and Beverage Undisputed 01/23/2026 1104305750 CMS
AstraZeneca Pharmaceuticals LP $0.79 04/16/2024 Food and Beverage Undisputed 01/23/2026 1104308068 CMS
AstraZeneca Pharmaceuticals LP $22.55 04/17/2024 Food and Beverage Undisputed 01/23/2026 1105848325 CMS
AstraZeneca Pharmaceuticals LP $28.44 06/11/2024 Food and Beverage Undisputed 01/23/2026 1105734101 CMS
AstraZeneca Pharmaceuticals LP $27.02 07/23/2024 Food and Beverage Undisputed 01/23/2026 1104504692 CMS
AstraZeneca Pharmaceuticals LP $30.30 08/08/2024 Food and Beverage Undisputed 01/23/2026 1105807942 CMS
AstraZeneca Pharmaceuticals LP $29.35 09/12/2024 Food and Beverage Undisputed 01/23/2026 1105702250 CMS
AstraZeneca Pharmaceuticals LP $27.27 10/17/2024 Food and Beverage Undisputed 01/23/2026 1105547903 CMS
E.R. Squibb & Sons, L.L.C. $42.75 10/15/2024 Food and Beverage Undisputed 01/23/2026 1101248283 CMS
EMD Serono, Inc. $9.18 04/18/2024 Food and Beverage Undisputed 01/23/2026 1120221729 CMS
EMD Serono, Inc. $27.92 04/18/2024 Food and Beverage Undisputed 01/23/2026 1120221917 CMS
EMD Serono, Inc. $44.09 07/11/2024 Food and Beverage Undisputed 01/23/2026 1120244663 CMS
EMD Serono, Inc. $29.13 09/09/2024 Food and Beverage Undisputed 01/23/2026 1120252874 CMS
EMD Serono, Inc. $31.21 10/03/2024 Food and Beverage Undisputed 01/23/2026 1120263710 CMS
EMD Serono, Inc. $30.41 11/06/2024 Food and Beverage Undisputed 01/23/2026 1120264093 CMS
EMD Serono, Inc. $20.32 12/06/2024 Food and Beverage Undisputed 01/23/2026 1120264009 CMS
Gilead Sciences, Inc. $14.19 02/01/2024 Food and Beverage Undisputed 01/23/2026 1133810975 CMS
Gilead Sciences, Inc. $18.97 03/07/2024 Food and Beverage Undisputed 01/23/2026 1133810977 CMS
Gilead Sciences, Inc. $22.00 05/01/2024 Food and Beverage Undisputed 01/23/2026 1133810979 CMS
Gilead Sciences, Inc. $28.25 05/31/2024 Food and Beverage Undisputed 01/23/2026 1133810981 CMS
Gilead Sciences, Inc. $21.76 08/29/2024 Food and Beverage Undisputed 01/23/2026 1133810983 CMS
Gilead Sciences, Inc. $25.10 09/23/2024 Food and Beverage Undisputed 01/23/2026 1133810985 CMS
Gilead Sciences, Inc. $28.01 10/18/2024 Food and Beverage Undisputed 01/23/2026 1133810987 CMS
Gilead Sciences, Inc. $24.92 11/07/2024 Food and Beverage Undisputed 01/23/2026 1133810989 CMS
Gilead Sciences, Inc. $28.58 12/11/2024 Food and Beverage Undisputed 01/23/2026 1133810991 CMS
Gilead Sciences, Inc. $24.23 12/17/2024 Food and Beverage Undisputed 01/23/2026 1133810993 CMS
Neurocrine Biosciences, Inc. $37.59 04/08/2024 Food and Beverage Undisputed 01/23/2026 1150816544 CMS
Neurocrine Biosciences, Inc. $36.99 05/06/2024 Food and Beverage Undisputed 01/23/2026 1150817152 CMS
Neurocrine Biosciences, Inc. $37.42 05/10/2024 Food and Beverage Undisputed 01/23/2026 1150816690 CMS
Neurocrine Biosciences, Inc. $26.70 06/06/2024 Food and Beverage Undisputed 01/23/2026 1150834624 CMS
Neurocrine Biosciences, Inc. $35.42 07/19/2024 Food and Beverage Undisputed 01/23/2026 1150818548 CMS
Neurocrine Biosciences, Inc. $39.71 09/04/2024 Food and Beverage Undisputed 01/23/2026 1150814990 CMS
Neurocrine Biosciences, Inc. $21.35 09/19/2024 Food and Beverage Undisputed 01/23/2026 1150853603 CMS
Neurocrine Biosciences, Inc. $22.05 10/05/2024 Food and Beverage Undisputed 01/23/2026 1150851070 CMS
Neurocrine Biosciences, Inc. $38.75 10/08/2024 Food and Beverage Undisputed 01/23/2026 1150815838 CMS
Neurocrine Biosciences, Inc. $29.41 10/18/2024 Food and Beverage Undisputed 01/23/2026 1150827234 CMS
Neurocrine Biosciences, Inc. $27.52 11/19/2024 Food and Beverage Undisputed 01/23/2026 1150832484 CMS
Neurocrine Biosciences, Inc. $35.76 12/18/2024 Food and Beverage Undisputed 01/23/2026 1150818236 CMS
Teva Pharmaceuticals USA, Inc. $114.52 01/12/2024 Food and Beverage Undisputed 01/23/2026 1151644011 CMS
Teva Pharmaceuticals USA, Inc. $31.67 01/16/2024 Food and Beverage Undisputed 01/23/2026 1151644013 CMS
Teva Pharmaceuticals USA, Inc. $6.56 01/17/2024 Food and Beverage Undisputed 01/23/2026 1151643991 CMS
Teva Pharmaceuticals USA, Inc. $22.64 01/17/2024 Food and Beverage Undisputed 01/23/2026 1151643993 CMS
Teva Pharmaceuticals USA, Inc. $39.45 02/06/2024 Food and Beverage Undisputed 01/23/2026 1151644023 CMS
Teva Pharmaceuticals USA, Inc. $27.22 02/25/2024 Food and Beverage Undisputed 01/23/2026 1151644025 CMS
Teva Pharmaceuticals USA, Inc. $30.91 03/23/2024 Food and Beverage Undisputed 01/23/2026 1151644031 CMS
Teva Pharmaceuticals USA, Inc. $28.95 04/03/2024 Food and Beverage Undisputed 01/23/2026 1151644033 CMS
Teva Pharmaceuticals USA, Inc. $4.06 04/04/2024 Food and Beverage Undisputed 01/23/2026 1151644035 CMS
Teva Pharmaceuticals USA, Inc. $35.07 04/30/2024 Food and Beverage Undisputed 01/23/2026 1151644047 CMS
Teva Pharmaceuticals USA, Inc. $34.58 05/10/2024 Food and Beverage Undisputed 01/23/2026 1151644049 CMS
Teva Pharmaceuticals USA, Inc. $30.49 07/09/2024 Food and Beverage Undisputed 01/23/2026 1151644057 CMS
Teva Pharmaceuticals USA, Inc. $3.94 07/10/2024 Food and Beverage Undisputed 01/23/2026 1151644059 CMS
Teva Pharmaceuticals USA, Inc. $35.42 07/29/2024 Food and Beverage Undisputed 01/23/2026 1151644061 CMS
ViiV Healthcare Company $27.93 03/28/2024 Food and Beverage Undisputed 01/23/2026 1112749040 CMS
ViiV Healthcare Company $29.23 04/10/2024 Food and Beverage Undisputed 01/23/2026 1112718234 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.